-
May 29: The Week in Cancer News
A study shows that a more tolerable, dose-adjusted chemotherapy regimen can effectively treat a rare lymphoma, and data from registries provide information on which cancer patients are at greatest risk of death from COVID-19.
by Kate Yandell
-
Registries Report on COVID-19 and Cancer
Data shed light on risk factors for death among people with cancer infected with the coronavirus.
by Kate Yandell
-
May 22: The Week in Cancer News
A study finds that metastatic prostate cancer incidence rose after the U.S. Preventive Services Task Force urged against routine PSA testing, and the Food and Drug Administration approves two PARP inhibitors for treatment of prostate cancer.
by Kate Yandell
-
When COVID-19 Comes Home
I have brain cancer, and my wife is a health care worker. These are some questions we had to consider leading up to and after her diagnosis with COVID-19.
by Adam Hayden
-
May 15: The Week in Cancer News
A study indicates that children with cancer are not at increased risks of severe cases of COVID-19, and researchers find that Medicaid expansion was associated with reduced cancer deaths.
by Kate Yandell
-
What It’s Like to Get a “C” in Graduate School
I was afraid that my thyroid cancer diagnosis would derail my graduate school plans. Instead, it helped shape my career path.
by Carly Flumer
-
May 8: The Week in Cancer News
A study finds that opioid deaths have slightly increased among people with cancer, and the Food and Drug Administration approves a targeted therapy for non-small cell lung cancer.
by Kate Yandell
-
Embracing Palliative Care Sooner
Studies show the benefits palliative care can provide to advanced cancer patients, but also highlight inequities in access.
by Jen Tota McGivney
-
May 1: The Week in Cancer News
At the AACR Virtual Annual Meeting I, researchers presented new data on cancer biology, treatment, screening and risk reduction.
by Cancer Today Staff
Cancer Talk
Declining Breast Cancer Mortality in Younger Women
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin